What is it about?

The number of victims of the COVID-19 pandemic shows important geographical differences. In this study, a number of human genetic polymorphisms were compared to the number of Covid-19 patients and Covid-19 mortality. Data from 33 countries were analyzed. Among the polymorphisms tested, the human angiotensine converting enzyme (ACE) polymorphism turned out to be a determinant factor in both prevalence and mortality. The present findings may partly explain why some countries are more affected than others by the Covid-19 pandemic.

Featured Image

Read the Original

This page is a summary of: COVID-19 infections are also affected by human ACE1 D/I polymorphism, Clinical Chemistry and Laboratory Medicine (CCLM), April 2020, De Gruyter,
DOI: 10.1515/cclm-2020-0425.
You can read the full text:



The following have contributed to this page